Related Experiment Videos
[Prazosin--a new antihypertensive agent (author's transl)]
Deutsche Medizinische Wochenschrift (1946)
|June 4, 1976
Summary
Prazosin effectively lowers blood pressure in patients with essential hypertension, showing significant reductions in systolic and diastolic pressure within one month. This hypertension treatment demonstrated sustained efficacy over six months with no significant side effects observed.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Context:
- Essential hypertension is a common cardiovascular condition requiring effective management.
- Prazosin is an alpha-1 adrenergic blocker used for hypertension treatment.
Purpose:
- To evaluate the efficacy and safety of prazosin in patients with essential hypertension.
- To assess blood pressure changes and side effects over a 6-month treatment period.
Summary:
- Forty patients with varying degrees of essential hypertension received prazosin for up to 6 months.
- Significant reductions in systolic and diastolic blood pressure were observed after one month, with further improvements at 3 and 6 months.
- Orthostatic disorders present at baseline resolved within weeks, and no drug-related side effects were definitively identified.
Impact:
- Prazosin demonstrates significant efficacy in lowering blood pressure for essential hypertension patients.
- The medication is well-tolerated, with a favorable safety profile and resolution of initial side effects like orthostatic disorders.
- This study supports prazosin as a viable treatment option for managing essential hypertension.